Credit Suisse Starts Endava PLC (ADR) (DAVA) at Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Deutsche Bank Starts Endava PLC (ADR) (DAVA) at Hold
August 22, 2018 5:01 AM EDTDeutsche Bank analyst Bryan Keane initiates coverage on Endava PLC (ADR) (NYSE: DAVA) with a Hold rating and a price target of $29.00.
For an analyst ratings summary and ratings history on Endava PLC (ADR)... More
Citi Starts Endava PLC (ADR) (DAVA) at Neutral
August 21, 2018 6:40 AM EDTCiti analyst Ashwin Shirvaikar initiates coverage on Endava PLC (ADR) (NYSE: DAVA) with a Neutral rating and a price target of $30.00.
The analyst likes the company but feels the equity is a bit "pricey." Shirvaikar believes the valuation is full given it has... More
William Blair Starts Endava PLC (ADR) (DAVA) at Outperform
August 21, 2018 6:04 AM EDTWilliam Blair analyst Maggie Nolan initiates coverage on Endava PLC (ADR) (NYSE: DAVA) with a Outperform rating.
For an analyst ratings summary and ratings history on Endava PLC (ADR) click here. For more ratings news on Endava PLC (ADR) click here.
Shares of Endava PLC (ADR) closed at $27.49 yesterday.
... MoreCowen Starts Endava PLC (ADR) (DAVA) at Outperform
August 21, 2018 6:01 AM EDTCowen analyst Bryan Bergin initiates coverage on Endava PLC (ADR) (NYSE: DAVA) with a Outperform rating and a price target of $35.00.
The analyst comments "DAVA's pure-play Digital offer drives 20%+ organic growth & above-avg op margins for 30% avg med-term EPS expansion. We cite strong management and a... More
